The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ATMEL CORP | COM | 049513104 | 6,559 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
FACEBOOK INC | CL A | 30303M102 | 18,707 | 278,000 | SH | SOLE | 278,000 | 0 | 0 | ||
GENERAL ELECTRIC CO | COM | 369604103 | 1,979 | 75,300 | SH | SOLE | 75,300 | 0 | 0 | ||
GENERAL MTRS CO | *W EXP 07/10/201 | 37045V126 | 11,919 | 353,583 | SH | SOLE | 353,583 | 0 | 0 | ||
GENERAL MTRS CO | COM | 37045V100 | 1,739 | 47,900 | SH | SOLE | 47,900 | 0 | 0 | ||
GOOGLE INC | CL A | 38259P508 | 17,373 | 30,200 | SH | SOLE | 30,200 | 0 | 0 | ||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 217 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
ISHARES | RUSSELL 2000 ETF | 464287655 | 1,071 | 9,018 | SH | SOLE | 9,018 | 0 | 0 | ||
ISHARES | RUSSELL 2000 ETF | 464287655 | 130,691 | 1,100,000 | SH | Call | SOLE | 0 | 0 | 0 | |
ISHARES | RUSSELL 2000 ETF | 464287655 | 118,810 | 1,000,000 | SH | Put | SOLE | 1,000,000 | 0 | 0 | |
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 151,683 | 775,000 | SH | Put | SOLE | 775,000 | 0 | 0 | |
ZELTIQ AESTHETICS INC | COM | 98933Q108 | 5,947 | 391,523 | SH | SOLE | 391,523 | 0 | 0 |